FAAH Antikörper (AA 201-300) (AbBy Fluor® 350)
Kurzübersicht für FAAH Antikörper (AA 201-300) (AbBy Fluor® 350) (ABIN895881)
Target
Alle FAAH Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-300
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Dog,Cow,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human FAAH1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- FAAH (Fatty Acid Amide Hydrolase (FAAH))
-
Andere Bezeichnung
- FAAH1
-
Hintergrund
-
Synonyms: Anandamide amidohydrolase 1, Anandamide amidohydrolase, FA2H, FAAH, FAAH-1, FAAH1_HUMAN, Fatty acid 2-hydroxylase, Fatty acid alpha-hydroxylase, Fatty acid amide hydrolase, Fatty-acid amide hydrolase 1, MGC102823, MGC138146, Oleamide hydrolase 1, Oleamide hydrolase.
Background: Degrades bioactive fatty acid amides like oleamide, the endogenous cannabinoid, anandamide and myristic amide to their corresponding acids, thereby serving to terminate the signaling functions of these molecules. Hydrolyzes polyunsaturated substrate anandamide preferentially as compared to monounsaturated substrates.
-
Gen-ID
- 124790
-
Pathways
- Monocarboxylic Acid Catabolic Process
Target
-